24 Participants NeededMy employer runs this trial

CRD3874-SI for AML

Recruiting at 6 trial locations
ES
AG
Overseen ByAaron Goldberg, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 1
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid leukemia (AML).

Who Is on the Research Team?

ES

Eytan Stein, MD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Are You a Good Fit for This Trial?

This trial is for people diagnosed with acute myeloid leukemia (AML) who are looking for new treatment options. Specific eligibility details aren't provided, but generally participants must have AML and meet certain health requirements.

Inclusion Criteria

I have HIV, but my viral load has been undetectable for the past 6 months.
Participant must weigh at least 40 kg
Calculated creatinine clearance ≥ 60 mL/min by Cockcroft-Gault, CKD-EPI 2021, or local institutional age-appropriate formula
See 8 more

Exclusion Criteria

My chronic myeloid leukemia is in the blast phase.
Presence of any condition increasing risk or making patient inappropriate for study per investigator opinion
Known prior severe hypersensitivity to investigational product or components including PEG (NCI CTCAE v6.0 Grade ≥ 3)
See 20 more

What Are the Treatments Tested in This Trial?

Interventions

  • CRD3874-SI

Trial Overview

The study is testing a new drug called CRD3874-SI to see if it is safe for treating people with AML. All participants will receive this medication as part of the research.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: 1.4 mg/kg CRD3874-SIExperimental Treatment1 Intervention
Group II: 0.9 mg/kg CRD3874-SIExperimental Treatment1 Intervention
Group III: 0.6 mg/kg CRD3874-SIExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+